SAFit-2

N/A

Report date: 2025/03/20 15:03:35
NME

Base Information

Drug NameSAFit-2
Drug Alias NameFKBP51 inhibitor (Buck Institute/Technical University Darmstadt)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTechnische Universität Darmstadt
China Registration ClassN/A

Develop Information

Active CompaniesTechnische Universität DarmstadtBuck Institute
Inactive CompaniesN/A
Active IndicationsHuntington Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A